Can You Overdose on Drugs? Signs, Risks & What to Do
Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated September 2026
Quick answer: Overdose means taking enough of a drug to trigger life-threatening toxicity. Opioids depress breathing until it stops; stimulants overdrive the heart; sedatives compound each other. Anyone can overdose — first-time users included.
What overdose actually is
An overdose is a toxic dose — more than the body can clear safely. It is not a moral failing or a sign of addiction; it is a medical emergency. The three big mechanisms: respiratory depression (opioids, benzodiazepines, alcohol), cardiac overstimulation (cocaine, meth, MDMA), and organ toxicity (acetaminophen, certain stimulants).
Warning signs
Opioid: slow/shallow breathing, pinpoint pupils, unresponsiveness, blue lips or fingertips, snoring/gurgling. Stimulant: chest pain, racing pulse, seizure, overheating, agitation, paranoia. Sedative: extreme drowsiness, confusion, slurred speech, falling asleep mid-conversation.
What to do
Call 911 immediately — most states have Good Samaritan laws protecting the caller. If naloxone (Narcan) is available and opioids are suspected, administer it. Do not leave the person alone; do not make them walk, drink coffee, or take a cold shower — none of that reverses toxicity.
Overdose and drug testing
An overdose does not change how long a drug stays detectable — detection windows are set by metabolism and specimen, not by how much you took. But an ER visit for overdose often triggers a toxicology panel, and a hospital record of overdose can surface in pre-employment or insurance screening. If you survived an overdose, the evidence-based next step is treatment, not detox products.
Certified labs nationwide · Results in 1–2 days
Need a test? Order online, test same-day →People also ask
Do prescriptions count against me?
No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.
Sources & further reading
- SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
- DOT — 49 CFR Part 40 procedures for transportation workplace testing
- Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
- FDA — drug-of-abuse test device labeling (detection window conventions)